Colitis, Lymphocytic: Clinical Trials

6 trials for Colitis, Lymphocytic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated, 1 unknown. 3 Phase 3, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Terminated 1
Not applicable1Unknown 1
Phase 21Terminated 1

Follow Colitis, Lymphocytic: new trials by email Literature Review of Colitis, Lymphocytic trials Research Report on Colitis, Lymphocytic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Systems Biology of Gastrointestinal and Related Diseases
Ulcerative Colitis, Crohn Disease
TerminatedViome172022-11-112023-12-15
Case-Control Study to Identify Risk Factors for Microscopic Colitis
Whole saliva sample - Microscopic Colitis, Collagenous Colitis
CompletedMaastricht University Medical Center4872014-07-012016-07-19
Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis
Budesonide, Mesalamine, Placebo - Lymphocytic Colitis
Phase 3CompletedDr. Falk Pharma GmbH572010-05-012017-07-26
Usefulness of Chromoendoscopy in Diagnosing Microscopic Colitis
Colonoscopy with Indigo-Carmine Chromoendoscopy - Chronic Diarrhoea, Lymphocytic Colitis
Not applicableUnknownKarolinska University Hospital1502009-06-012015-08-06
Budesonide Versus Placebo for the Treatment of Lymphocytic Colitis
Placebo, Budesonide - Lymphocytic Colitis, Diarrhea
Phase 2 / Phase 3TerminatedMayo Clinic162003-06-012021-11-02
Budesonide Treatment for Lymphocytic Colitis
Budesonide - Microscopic Colitis
Phase 3CompletedTechnische Universität Dresden402002-01-012010-03-30

Narrower conditions

Colitis, Microscopic (4)  ·  Colitis, Collagenous (2)  ·  Barrett Esophagus (1)  ·  Celiac Disease (1)  ·  Cholelithiasis (1)  ·  Colitis, Ulcerative (1)  ·  Colonic Polyps (1)  ·  Crohn Disease (1)  ·  Diarrhea (1)  ·  Duodenal Ulcer (1)  ·  Eosinophilic Esophagitis (1)  ·  Esophageal Neoplasms (1)  ·  Gastritis (1)  ·  Gastroesophageal Reflux (1)

Broader conditions

Colitis (6)  ·  Colonic Diseases (6)  ·  Digestive System Diseases (6)  ·  Gastroenteritis (6)  ·  Gastrointestinal Diseases (5)  ·  Intestinal Diseases (5)  ·  Colitis, Microscopic (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Biliary Tract Diseases (1)  ·  Body Weight (1)  ·  Colonic Diseases, Functional (1)  ·  Deglutition Disorders (1)  ·  Digestive System Neoplasms (1)  ·  Duodenal Diseases (1)

Interventions

Budesonide (3)  ·  Colonoscopy (1)  ·  Indigo Carmine (1)  ·  Mesalamine (1)

Sponsors

Dr. Falk Pharma GmbH (1)  ·  Karolinska University Hospital (1)  ·  Maastricht University Medical Center (1)  ·  Mayo Clinic (1)  ·  Technische Universität Dresden (1)  ·  Viome (1)

Countries

Germany (2)  ·  United States (2)  ·  Netherlands (1)  ·  Sweden (1)

Top investigators

Ad AM Masclee, Prof. (1)  ·  Darrell S. Pardi, M.D. (1)  ·  Marieke J Pierik, MD, PhD (1)  ·  Momchilo Vuyisich (1)  ·  Peter T Schmidt, MD, PhD (1)  ·  Stephan Miehlke, Prof. (1)  ·  Stephan Miehlke, Professor (1)

Results publications

PMID 30195447

NIH funding

2008 (1), UL1RR024150 (1)